Porter 2020: armodafinil vs placebo
Adverse events (grade ≥ 3) · people with a primary brain tumour
1 finding from 1 review
- Interventions for the management of fatigue in adults with a primary brain tumour 2022 · Cochrane Headline outcomes onlyno estimate extracted1 study · 328 participantsLow